Heron Therapeutics Announces Appointment Of Ira Duarte As Chief Financial Officer
Portfolio Pulse from Benzinga Newsdesk
Heron Therapeutics has announced the appointment of Ira Duarte as its new Chief Financial Officer. Duarte brings extensive experience in finance and operations, which will be valuable for the company's growth.
June 23, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Heron Therapeutics appoints Ira Duarte as CFO, potentially strengthening the company's financial management and supporting growth.
Ira Duarte's appointment as CFO of Heron Therapeutics is expected to have a positive impact on the company's stock price in the short term. Duarte's extensive experience in finance and operations will likely strengthen the company's financial management and support its growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100